ProteoSign statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool ProteoSign
info

Tool usage distribution map

info info

Associated diseases

info

Popular tool citations

chevron_left Differential protein expression chevron_right
Want to access the full stats & trends on this tool?

ProteoSign specifications

Information


Unique identifier OMICS_18441
Name ProteoSign
Interface Web user interface
Restrictions to use None
Input data The input file(s) should be made out of merging multiple LC-MS/MS runs (fractionation, replication) of a single, possibly multiplexed, experiment and should not be the result of merging different or parallel experiments.
Input format TXT
Programming languages Javascript, PHP
Computer skills Basic
Version 1.0
Stability Stable
Maintained Yes

Maintainer


  • person_outline Ioannis Iliopoulos

Publication for ProteoSign

ProteoSign citation

library_books

Calcitriol Supplementation Causes Decreases in Tumorigenic Proteins and Different Proteomic and Metabolomic Signatures in Right versus Left Sided Colon Cancer

2018
PMCID: 5875995
PMID: 29324674
DOI: 10.3390/metabo8010005

[…] determine the false discovery rate (FDR) set to 0.01. iTRAQ 8-plex was used as the reporter ion quantitation type as well as instrument Orbitrap MS and MS/MS. Further data analysis was performed with ProteoSign, a web-based software for differential protein analysis []. Functional classification was performed using Ingenuity Pathway Analysis (IPA). […]


Want to access the full list of citations?
ProteoSign institution(s)
Medical School, Division of Basic Sciences, University of Crete, Heraklion, Greece; Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK; Lawrence Berkeley National Labs, DOE Joint Genome Institute, Walnut Creek, CA, USA; Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Greece; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA
ProteoSign funding source(s)
Supported by Wellcome Trust [WT094296MA and EU-FP7 ‘Sybilla’ number 201106]; EU-FP7 project InnovCrete.

ProteoSign reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ProteoSign